MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway

BACKGROUND: Increasing evidences demonstrate that miRNAs contribute to development and progression of hepatocellular carcinoma (HCC). Underexpression of miR-1296 is recently reported to promote growth and metastasis of human cancers. However, the expression and role of miR-1296 in HCC remain unknown...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Mol Cancer
Asıl Yazarlar: Xu, Qiuran, Liu, Xin, Liu, Zhikui, Zhou, Zhenyu, Wang, Yufeng, Tu, Jianfeng, Li, Lijie, Bao, Hangxing, Yang, Liu, Tu, Kangsheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2017
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5469159/
https://ncbi.nlm.nih.gov/pubmed/28606154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12943-017-0675-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller